How do I subscribe to ongoing alerts?

Subscribe to /feed/company/translational-research-center-for-medical-innovation-kobe-hyogo-japan.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan pipeline: 0 marketed, 0 filed, 6 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 6 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
fiblast,gelatin sponge,fibrin glue	fiblast,gelatin sponge,fibrin glue	phase 3
Asprin, Cilostazol	Asprin, Cilostazol	phase 3	Antiplatelet combination therapy	COX-1 (aspirin); PDE-3 (cilostazol)	Cardiovascular
UFT adjuvant chemotherapy	UFT adjuvant chemotherapy	phase 3	Antimetabolite chemotherapy	Thymidylate synthase	Oncology
Non-PPI (Gefarnate)	Non-PPI (Gefarnate)	phase 3	Mucoprotective agent		Gastroenterology
tacrolimus + steroid	tacrolimus + steroid	phase 3	immunosuppressant	calcineurin	Immunology
tacrolimus + mycophenolate mofetil	tacrolimus + mycophenolate mofetil	phase 3	Immunosuppressant combination	Calcineurin (tacrolimus); Inosine monophosphate dehydrogenase (mycophenolate mofetil)	Immunology / Transplantation

Therapeutic area mix

Cardiovascular · 1
Gastroenterology · 1
Immunology · 1
Immunology / Transplantation · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Centre Hospitalier Universitaire, Amiens · 1 shared drug class
DH Bio Co., Ltd. · 1 shared drug class
Glenmark Pharmaceuticals Ltd. India · 1 shared drug class
Hoffmann-La Roche · 1 shared drug class
Jiangsu HengRui Medicine Co., Ltd. · 1 shared drug class
Kaiser Franz Josef Hospital · 1 shared drug class
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan:

Cite this brief

Drug Landscape (2026). Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/translational-research-center-for-medical-innovation-kobe-hyogo-japan. Accessed 2026-05-17.